(Circulation. 2006;113:2679-2682.)
© 2006 American Heart Association, Inc.
Editorial |
From BIOrest Ltd, Tel-Aviv, Israel (Y.R.); and the Cardiovascular Division, Department of Medicine, Brigham and Womens Hospital, Boston, and Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Mass (E.R.E.).
Correspondence to Dr Yoram Richter, BIOrest Ltd, POB 58187, Tel-Aviv 61581 Israel (e-mail yrichter@biorest.co.il), or Dr Elazer Edelman, Department of Medicine, Brigham and Womens Hospital, 75 Francis St, Boston MA 02115 (e-mail ere@mit.edu).
Key Words: Editorials angiography angioplasty atherosclerosis blood flow diagnosis hemodynamics
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Panta rhei. (Everything flows).1
Cardiology is about flow. The primary purpose of the cardiovascular system is to drive, control, and maintain blood flow to all parts of the body. Flow dictates the form and function of the heart and blood vessels through ontogenic and phylogenic development, the structural and functional consequence of repair, and in its end stages, remodeling and response to failure. Flow should therefore be a primary focus by which we explain where lesions form, why they degrade and decompensate, and how we grade the extent of restoration of function after vascular intervention. Yet this is not the case. Flow is not a standard part of our clinical lexicon. Few reliable and consistent means of measuring flow exist. Despite early use of surrogate flow markers (eg, TIMI frame count), we do not quantify flow restoration after interventions. Moreover, there is simply no agreement as to the aspect or degree of flow that is most important in lesion development or functional recovery.
Article p 2744
| Flow and Atherogenesis |
|---|
This article has been cited by other articles:
![]() |
M. Joner, G. Nakazawa, A. V. Finn, S. C. Quee, L. Coleman, E. Acampado, P. S. Wilson, K. Skorija, Q. Cheng, X. Xu, et al. Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents J. Am. Coll. Cardiol., July 29, 2008; 52(5): 333 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Weigang, F. A. Kari, F. Beyersdorf, M. Luehr, C. D. Etz, A. Frydrychowicz, A. Harloff, and M. Markl Flow-sensitive four-dimensional magnetic resonance imaging: flow patterns in ascending aortic aneurysms. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone Reply J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2171 - 2172. [Full Text] [PDF] |
||||
![]() |
A. Frydrychowicz, C. Schlensak, A. Stalder, M. Russe, M. Siepe, F. Beyersdorf, M. Langer, J. Hennig, and M. Markl Ascending-descending aortic bypass surgery in aortic arch coarctation: Four-dimensional magnetic resonance flow analysis J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 260 - 262. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |